NOS2 and neoplasm: This unbiased analysis spatially identifies targetable biomarkers that promote immunosuppressive cellular neighborhoods with predictive value, which include increases in both NOS2+ and COX2+ tumor clusters in spatially distinct cellular regions that drive immunosuppression and ER– breast tumor metastasis.